AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
VORICONAZOLE
33 registrations across 10 African markets— 26 active
Markets with VORICONAZOLE
🇿🇦South Africa
14 registrations
14 active
🇹🇳Tunisia
6 registrations
0 active
🇲🇦Morocco
3 registrations
3 active
🇺🇬Uganda
2 registrations
2 active
🇿🇲Zambia
2 registrations
2 active
🇰🇪Kenya
2 registrations
2 active
🇿🇼Zimbabwe
1 registration
1 active
🇲🇼Malawi
1 registration
0 active
🇳🇬Nigeria
1 registration
1 active
🇹🇿Tanzania
1 registration
1 active
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Voriole 200mg tablets. Tablet | 🇰🇪Kenya | MSN Laboratories Private Limited | active | May 2031 |
| VORIOLE 50 Tablet | 🇰🇪Kenya | MSN Laboratories Private Limited | active | May 2031 |
| Voriole 50 tablets Film Coated Tablets | 🇿🇲Zambia | MSN Laboratories Private Limited | active | Dec 2030 |
| VORICONAZOLE 200 mg FRESENIUS | 🇿🇦South Africa | Fresenius Kabi South Africa (Pty) Ltd | active | Oct 2029 |
| GLEZOLE 200 mg | 🇿🇦South Africa | Glenmark Pharmaceuticals South Africa (Pty) Ltd | active | Aug 2029 |
| GLEZOLE 50 mg | 🇿🇦South Africa | Glenmark Pharmaceuticals South Africa (Pty) Ltd | active | Aug 2029 |
| Voriole 200 tablets Tablet Uncoated | 🇿🇲Zambia | MSN Laboratories Private Limited | active | Jun 2029 |
| HETEVORI | 🇿🇦South Africa | Hetero Drugs South Africa (Pty) Ltd | active | May 2029 |
| VORICONAZOLE INJ HETERO | 🇿🇦South Africa | Hetero Drugs South Africa (Pty) Ltd | active | May 2029 |
| VOSARIC | 🇿🇦South Africa | Hetero Drugs South Africa (Pty) Ltd | active | May 2029 |
| IMMAVOR | 🇿🇦South Africa | Ruby Pharmaceuticals (Pty) Ltd | active | Feb 2028 |
| IMMANAZ | 🇿🇦South Africa | Ruby Pharmaceuticals (Pty) Ltd | active | Feb 2028 |
| CANDIVOR POWDER/INJECTABLE; INJECTION | 🇿🇼Zimbabwe | HETERO LABS LTD | active | Jan 2028 |
| Vfend 200 mg Tablets** Tablet | 🇳🇬Nigeria | Pfizer Specialties Ltd | active | Nov 2025 |
| VFEND Poudre pour solution pour perfusion / 200 mg | 🇹🇳Tunisia | PFIZER Europe MA EEIG | expired | Mar 2020 |
| VFEND Comprimé pelliculé / 200 mg | 🇹🇳Tunisia | PFIZER Europe MA EEIG | expired | Mar 2020 |
| VFEND Comprimé pelliculé / 50 mg | 🇹🇳Tunisia | PFIZER Europe MA EEIG | expired | Mar 2020 |
| VFEND Poudre pour suspension orale / 40 mg/ml | 🇹🇳Tunisia | PFIZER Europe MA EEIG | expired | Mar 2020 |
| CANDIVOR 200MG/VIAL INECTION INECTION | 🇲🇼Malawi | — | expired | Jun 2019 |
| VORICO Comprimé pelliculé / 50 mg | 🇹🇳Tunisia | PHILADELPHIA PHARMA | expired | Dec 2016 |
| VORICO Comprimé pelliculé / 200 mg | 🇹🇳Tunisia | PHILADELPHIA PHARMA | expired | Dec 2016 |
| VORICONAZOLE 200 ACCORD | 🇿🇦South Africa | Accord Healthcare (Pty) Ltd | active | Jan 1900 |
| VORICONAZOLE 50 ACCORD | 🇿🇦South Africa | Accord Healthcare (Pty) Ltd | active | Jan 1900 |
| VFEND 50 mg | 🇿🇦South Africa | Pfizer Laboratories (Pty) Ltd | active | Jan 1900 |
| VFEND 200 mg | 🇿🇦South Africa | Pfizer Laboratories (Pty) Ltd | active | Jan 1900 |
| VFEND IV 200 mg | 🇿🇦South Africa | Pfizer Laboratories (Pty) Ltd | active | Jan 1900 |
| AVICONAL 200 | 🇿🇦South Africa | Accord Healthcare (Pty) Ltd | active | Jan 1900 |
| VFEND COMPRIME ENROBE | 🇲🇦Morocco | — | active | — |
| VFEND COMPRIME ENROBE | 🇲🇦Morocco | — | active | — |
| MyVorcon 200 Film Coated Tablet | 🇹🇿Tanzania | Mylan Laboratories Limited | active | — |
| VFEND POUDRE POUR PERFUSION | 🇲🇦Morocco | — | active | — |
| VORICONAZOLE PARENTERAL
ORDINARY DRY
VIALS | 🇺🇬Uganda | ASPIRO PHARMA LIMITED. | active | — |
| VORICONAZOLE PARENTERAL
ORDINARY DRY
VIALS | 🇺🇬Uganda | ASPIRO PHARMA LIMITED. | active | — |
VORICONAZOLE in Africa — Regulatory Overview
VORICONAZOLE is registered across 10 African markets with 33 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Tunisia, Morocco, Uganda and 6 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 33 registrations, 26 (79%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.